For more than 25 years, Pharmaceutical Strategies Group (PSG) has been relentlessly advocating for clients as they navigate the complex and ever-changing challenges of drug cost management. Our innovative consulting and technology solutions, including the proprietary data and analytics platform, Artemetrx, and our proprietary 340B program management solution, 340B Link, deliver actionable insights with exceptional financial and clinical value. As the largest independent pharmacy benefit consulting firm in the U.S., PSG functions as a strategic partner to self-insured employers, health plans, brokers, coalitions, and health systems, generating more than $4.8 billion in drug cost savings each year.
Our mission is to relentlessly advocate for our clients as we partner together to develop innovative drug management solutions that deliver exceptional insights with financial and clinical value.
Drawing on more than 25 years of pharmaceutical innovation and pharmacy-focused experience, we deploy proprietary technology, industry intelligence, actionable insights, data-enabled services and the industry’s most trusted advisors to help our clients reduce costs, enhance revenue, and optimize health outcomes.
From 340B program management and pharmacy benefit consulting to drug spend analytics and program compliance, we help you navigate the complex pharmaceuticals marketplace and leverage trending data and cost management opportunities. Our results deliver improved outcomes, lower costs, better performance, and allow our clients to transform challenges into opportunities.